Relay Therapeutics, Inc. ($RLAY)
Filing Information
| Accession Number | 0001193125-26-294528 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 2, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
53,056
Total Value
$975,739.20
P&L
+170.1% (+$36,121.92)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Corporate Development Officer | Common Stock | โ | Jun 30, 2026 | Sale | 50,000 | $19.09 | $954,500.00 | 225,857 | Direct | โ | View Details | |
Chief Corporate Development Officer | Common Stock | โ | Jun 30, 2026 | Grant/Award | 3,056 | $6.95 | $21,239.20 | 228,913 | Direct | โ | View Details |